Though adequate insulin production still needs to be optimized and glucose regulated insulin secretion would be ideal, these experiments demonstrate that SC retain their protective properties through genetic modification and might represent a viable option for treating diabetes. This evidence concerns the gene INS and diabetes mellitus.